---
figid: PMC6959184__1042337.fig1
figlink: /pmc/articles/PMC6959184/figure/f1-1042337/
number: F1
caption: The role of MYD88 signaling in normal physiology and lymphomagenesis. Recognition
  of pathogens by TLR, IL1R, and IL-18R induces an immune response through activation
  of MYD88 and generates the myddosome complex with IRAK4 and IRAK1 or IRAK2, which
  is stabilized by HSP110. IRAK1 and IRAK2 activate the MAPK and NF-κB pathways through
  TRAF6 and TAK1, causing proliferation and survival of B cells. MYD88(L265P) allows
  for increased formation of the myddosome complex, preferentially with IRAK1, and
  constitutively activates the NF-κB pathway. In addition, the formation of the My-T-BCR
  supercomplex leads to increased activation of mTOR and the CBM complex, promoting
  lymphomagenesis. Lastly, constitutively active NF-κB increases autocrine signaling
  of IL-6 and IL-10, which further promote B-cell proliferation and survival via the
  alternative JAK/STAT signaling cascade.
pmcid: PMC6959184
papertitle: 'MYD88 in the driver’s seat of B-cell lymphomagenesis: from molecular
  mechanisms to clinical implications.'
reftext: Ruben A.L. de Groen, et al. Haematologica. 2019 Dec;104(12):2337-2348.
pmc_ranked_result_index: '21749'
pathway_score: 0.966339
filename: 1042337.fig1.jpg
figtitle: The role of MYD88 signaling in normal physiology and lymphomagenesis
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6959184__1042337.fig1.html
  '@type': Dataset
  description: The role of MYD88 signaling in normal physiology and lymphomagenesis.
    Recognition of pathogens by TLR, IL1R, and IL-18R induces an immune response through
    activation of MYD88 and generates the myddosome complex with IRAK4 and IRAK1 or
    IRAK2, which is stabilized by HSP110. IRAK1 and IRAK2 activate the MAPK and NF-κB
    pathways through TRAF6 and TAK1, causing proliferation and survival of B cells.
    MYD88(L265P) allows for increased formation of the myddosome complex, preferentially
    with IRAK1, and constitutively activates the NF-κB pathway. In addition, the formation
    of the My-T-BCR supercomplex leads to increased activation of mTOR and the CBM
    complex, promoting lymphomagenesis. Lastly, constitutively active NF-κB increases
    autocrine signaling of IL-6 and IL-10, which further promote B-cell proliferation
    and survival via the alternative JAK/STAT signaling cascade.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL6
  - IL10
  - TLR1
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR8
  - TLR9
  - TLR2
  - TLR7
  - TLR10
  - IL1R1
  - BCR
  - HCK
  - PPP3R2
  - PPP3CA
  - PPP3CB
  - PPP3CC
  - PPP3R1
  - IRAK2
  - IRAK1
  - AKT2
  - AKT3
  - AKT1
  - MTOR
  - TRAF6
  - JAK3
  - PLCG2
  - MAP3K7CL
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - STAT3
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - MAPK14
  - MAPK3
  - MAPK8
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK1
  - MAPK9
  - MAPK10
  - MAK
  - IFNB1
  - CD79A
genes:
- word: IL-6/
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL-10
  symbol: IL-10
  source: hgnc_alias_symbol
  hgnc_symbol: IL10
  entrez: '3586'
- word: IL-6/IL-10receptor
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: TLR/IL-1R/IL-18R
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR1
  entrez: '7096'
- word: TLR/IL-1R/IL-18R
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: TLR/IL-1R/IL-18R
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: TLR/IL-1R/IL-18R
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR5
  entrez: '7100'
- word: TLR/IL-1R/IL-18R
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR6
  entrez: '10333'
- word: TLR/IL-1R/IL-18R
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
- word: TLR/IL-1R/IL-18R
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: TLR/IL-1R/IL-18R
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: TLR/IL-1R/IL-18R
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: TLR/IL-1R/IL-18R
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR10
  entrez: '81793'
- word: TLR/IL-1R/IL-18R
  symbol: IL1R
  source: hgnc_prev_symbol
  hgnc_symbol: IL1R1
  entrez: '3554'
- word: TLR/IL-1R/
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR1
  entrez: '7096'
- word: TLR/IL-1R/
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: TLR/IL-1R/
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: TLR/IL-1R/
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR5
  entrez: '7100'
- word: TLR/IL-1R/
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR6
  entrez: '10333'
- word: TLR/IL-1R/
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
- word: TLR/IL-1R/
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: TLR/IL-1R/
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: TLR/IL-1R/
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: TLR/IL-1R/
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR10
  entrez: '81793'
- word: TLR/IL-1R/
  symbol: IL1R
  source: hgnc_prev_symbol
  hgnc_symbol: IL1R1
  entrez: '3554'
- word: TLR9
  symbol: TLR9
  source: hgnc_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: BCR
  symbol: BCR
  source: hgnc_symbol
  hgnc_symbol: BCR
  entrez: '613'
- word: HCK
  symbol: HCK
  source: hgnc_symbol
  hgnc_symbol: HCK
  entrez: '3055'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3R2
  entrez: '5535'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CA
  entrez: '5530'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CB
  entrez: '5532'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3CC
  entrez: '5533'
- word: Calcineurin
  symbol: CALCINEURIN
  source: bioentities_symbol
  hgnc_symbol: PPP3R1
  entrez: '5534'
- word: IRAK1/2
  symbol: IRAK2
  source: hgnc_symbol
  hgnc_symbol: IRAK2
  entrez: '3656'
- word: IRAK1/2
  symbol: IRAK1
  source: hgnc_symbol
  hgnc_symbol: IRAK1
  entrez: '3654'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: JAKI
  symbol: JAKL
  source: hgnc_alias_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PLCY2
  symbol: PLCG2
  source: hgnc_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: TAKI
  symbol: TAKL
  source: hgnc_alias_symbol
  hgnc_symbol: MAP3K7CL
  entrez: '56911'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC1
  entrez: '4772'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC2
  entrez: '4773'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC3
  entrez: '4775'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFATC4
  entrez: '4776'
- word: NFAT
  symbol: NFAT
  source: bioentities_symbol
  hgnc_symbol: NFAT5
  entrez: '10725'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: МАРК
  symbol: MAK
  source: hgnc_symbol
  hgnc_symbol: MAK
  entrez: '4117'
- word: IFNB
  symbol: IFNB
  source: bioentities_symbol
  hgnc_symbol: IFNB1
  entrez: '3456'
- word: CD79A
  symbol: CD79A
  source: hgnc_symbol
  hgnc_symbol: CD79A
  entrez: '973'
chemicals: []
diseases: []
figid_alias: PMC6959184__F1
redirect_from: /figures/PMC6959184__F1
figtype: Figure
---
